Viewing Study NCT03488160


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2025-12-26 @ 3:13 AM
Study NCT ID: NCT03488160
Status: UNKNOWN
Last Update Posted: 2018-04-10
First Post: 2018-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma
Sponsor: Sinobioway Cell Therapy Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module